Search

Oral presentations: Scientific Session 9: Basic Science: The microbiome as game changer in IBD? (2021)

OP28 The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn’s Disease: Results from the phase 2 GALAXI 1 study

OP29 Long-term dietary patterns are associated with pro-inflammatory and anti-inflammatory features of the gut microbiome

OP30 Lyophilised orally administered faecal microbiota transplantation for Active Ulcerative Colitis (LOTUS study)

OP31 RESTORE: Interim analysis of a Phase 2 study of QBECO SSI for the induction and maintenance of clinical and endoscopic remission in subjects with Moderate to Severe Crohn’s Disease

OP32 Stool microbiome communities predict remission in treatment-naïve Pediatric Crohn’s Disease patients